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S U M M A R Y
Rickettsioses share common clinical manifestations, such as fever, malaise, exanthema, the presence or
absence of an inoculation eschar, and lymphadenopathy. Some of these manifestations can be suggestive
of certain species of Rickettsia infection. Nevertheless none of these manifestations are pathognomonic,
and direct diagnostic methods to conﬁrm the involved species are always required. A syndrome is a set of
signs and symptoms that characterizes a disease with many etiologies or causes. This situation is
applicable to rickettsioses, where different species can cause similar clinical presentations. We propose a
syndromic classiﬁcation for these diseases: exanthematic rickettsiosis syndrome with a low probability
of inoculation eschar and rickettsiosis syndrome with a probability of inoculation eschar and their
variants. In doing so, we take into account the clinical manifestations, the geographic origin, and the
possible vector involved, in order to provide a guide for physicians of the most probable etiological agent.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/3.0/).
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Rickettsioses are zoonotic infections caused by obligate
intracellular bacteria of the genera Rickettsia and Orientia,
belonging to the family Rickettsiaceae.1–3 The lifecycle of these
microorganisms is determined by their survival in small mammals
(which can act as reservoirs or as ampliﬁers) and in arthropods,
such as ticks, ﬂeas, lice, and mites, which can also act as vectors. In
this regard, and with the exception of Rickettsia prowazekii, the
human is usually an accidental host.4
From the ﬁrst description of R. prowazekii as an etiological agent
of epidemic typhus in 1916 up to the late 1980s, eight further
species were described as causes of rickettsioses around the world:
Rickettsia rickettsii, Rickettsia typhi, Rickettsia conorii subsp. conorii,
Rickettsia akari, Rickettsia sibirica, Rickettsia australis, Rickettsia
conorii subsp. israelensis, and Orientia tsutsugamushi.5 However,
with the development and implementation of molecular biology in
the 1990s, this list has since grown and more than 30 species and
subspecies are recognized. Most of them have been implicated as
human pathogens.6* Corresponding author. Tel.: +34 699607264.
E-mail address: jaoteo@riojasalud.es (J.A. Oteo).
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license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Rickettsioses have no pathognomonic signs, although there are
signs and symptoms that are highly suggestive, such as the
presence of fever, rash, lymphadenopathy, and an eschar (tache
noire). Unfortunately not always and not all rickettsioses present
typical signs and symptoms. In most cases clinical suspicion
together with a positive serology is sufﬁcient to make the diagnosis
of rickettsiosis, although in order to reach an accurate diagnosis
and conﬁrm the etiological agent, isolation or molecular biology
assays are needed.
By deﬁnition, a syndrome is a set of signs and symptoms that
characterizes a disease with several causes or etiologies.7 This
deﬁnition is applicable to rickettsioses because different species
can cause similar clinical presentations. Therefore, we propose a
syndromic classiﬁcation for these infections (exanthematic rick-
ettsiosis syndrome with a low probability of inoculation eschar and
rickettsiosis syndrome with a probability of inoculation eschar and
their variants) in order to provide clinicians with a guide to the
suspected etiological agent and thus direct the diagnosis taking the
clinical manifestations, geographic area, and the possible vector
involved into account. We provide only a brief description of the
recommended treatment, since the antibiotic management of
rickettsioses is simple (doxycycline, except where there are
contraindications) and remains the same regardless of the speciesciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Figure 1. Map showing the distribution of the main human tick-borne rickettsioses.
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human tick-borne rickettsioses.
2. Exanthematic rickettsioses syndrome with a low probability
of inoculation eschar
This is characterized by an acute febrile illness where a rash is
the predominant clinical manifestation and the presence of an
inoculation eschar cannot be seen or its presence is exceptional.
Two variants are proposed taking into account the distribution of
the rash (Figure 2).
2.1. With centripetal rash distribution
This type of rash is characteristic of the rickettsioses caused by
R. rickettsii. It occurs only in 3–5% in the ﬁrst 3 days, increasing to
60–70% between days 7 and 10 of the disease.8 It usually starts on
the wrists and ankles as small not itchy red macular lesions, with
subsequent extension to the extremities and palmoplantar andSyndrome
Type of rash  
Epidemiological background  
Cent ripeta l rash 
Exanthemac  rickesioses with low pr
The Americas
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Figure 2. Algorithm for exanthematic rickettsiosetrunk involvement. Maculopapular, petechial, or purpuric lesions
can be observed (Figure 3).9 In 10% of cases we do not observe rash,
generally in dark skin people and ederly people.10 In R. rickettsii
infection, the presence of an inoculation eschar is an unusual
ﬁnding (only ﬁve cases reported in the literature from 1981 to
2012).11–14
The geographical distribution of R. rickettsii, the most patho-
genic species of the tick-borne rickettsiae, is limited to the Western
Hemisphere where its primary vectors are ticks of the genera
Dermacentor, Rhipicephalus, and Amblyomma (Table 1).15
2.2. With centrifugal rash distribution
This is typical of R. typhi and R. prowazekii infections. The rash
usually starts on the trunk and spreads to the extremities without
palmoplantar involvement. In both rickettsioses, the exanthema is
characterized by macular, maculopapular, or petechial lesions.27
The latter lesions and compromise of the axillary area are
more frequent in R. prowazekii infection.28 Characteristically, anCentrifuga l ras h
obability of  inocula on eschar 
ro pical or  sub tro pical  area s 
and Med iterr anean  Area   
Fleas 
Popu la ons at  risk of parasism 
by body  li ce. Flying  squ irr els 
(USA)
R. typhi R. prowazekii
s and a low probability of inoculation eschar.
Figure 3. Purpuric rash on a patient with Rickettsia rickettsii rickettsiosis. Courtesy
of Dr Rodrigo Angerami.
Table 1
Exanthematic rickettsioses with a centripetal rash distribution and a low
probability of inoculation eschar
Rickettsia
species
Geographical
distribution
Known vector or
possible vectors
References
R. rickettsii America
Canada Dermacentor andersoni 16
USA Dermacentor variabilis,
D. andersoni,
Rhipicephalus sanguineus,
Amblyomma americanum
12,17,18
Mexico R. sanguineus, Amblyomma
cajennense sensu lato (s.l.)
16,19
Costa Rica Haemaphysalis leporispalustris 20
Panama A. cajennense s.l. 21
Colombia A. cajennense s.l. 22
Brazil A. cajennense s.l., Amblyomma
aureolatum, R. sanguineus
23–25
Argentina A. cajennense s.l. 26
Table 2
Exanthematic rickettsioses with a centrifugal rash distribution and a low
probability of inoculation eschar
Rickettsia
species
Geographical
distribution
Known vector or
possible vectors
References
R. typhi Worldwide Xenopsylla cheopis,
Ctenocephalides felis
29
R. prowazekii America Lice and ﬂeas from
ﬂying squirrels (USA)
32–36
USA (wild cycle)
Mexico, Guatemala,
Ecuador, Bolivia,
Chile, Argentina,
Peru, Colombia
Europe Pediculus humanus
humanus
France, Russia
Africa
Algeria, Burundi
Figure 4. Eschar (tache noire) on a patient with Rickettsia conorii rickettsiosis.
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rickettsioses, the rash is commonly missed on dark skin. In these
cases it is very important to look for scratches secondary to lice
parasitization or antecedents of bites in the case of ﬂeas. Also, in R.
prowazekii infection, the patient presents with confusion, purpura,
and gangrene may be observed.28
R. typhi has a worldwide distribution predominantly in tropical
and subtropical areas, where its main vector is the rat ﬂea
Xenopsylla cheopis, followed by Ctenocephalides felis.29 R. prowazekii
infection is related to outbreaks in populations at risk of parasitism
by body lice (Pediculus humanus humanus), where poor hygiene
and overcrowding are common (homeless, displaced, refugees, and
imprisoned).28 However, in the USA the eco-epidemiology of this
disease is often associated with the presence of and contact with
ﬂying squirrels (Glaucomys volans) and its ectoparasites, in which
an enzootic or wild cycle is described.30 Signiﬁcantly, R. prowazekii
is the only species of Rickettsia able to produce a latent infection
and subsequently manifests in a recrudescent way called ‘Brill–
Zinsser’ disease, where the presence of rash is less common
(Table 2).31
3. Rickettsioses syndrome with a probability of inoculation
eschar
This is characterized by an acute febrile illness with or without
rash, where one of the most common signs is the inoculation
eschar. An eschar is deﬁned as a crusty necrotic lesion with or
without a surrounding erythematous halo, which suggests the
location of the vector bite (Figure 4).37 This is one of the mostcommon clinical manifestations in different rickettsioses associ-
ated with tick bites and in O. tsutsugamushi infections.38 We
propose four syndrome variants taking into consideration other
associated signs (Figure 5 and Tables 3–6).
3.1. Associated with a maculopapular/purpuric rash
3.1.1. Rickettsia felis infection
Since the ﬁrst reports, R. felis disease has been identiﬁed by
clinical manifestations similar to those caused by R. typhi. It tends
to manifest a generalized maculopapular rash on the trunk, with
the difference that in some cases it also presents an inoculation
eschar associated with regional lymphadenopathy.39 However,
recent studies in Sub-Saharan Africa (Kenya and Senegal) show
that R. felis can also cause an acute non-speciﬁc febrile illness
without rash or inoculation eschar.40 In Senegal it has been
proposed as the primary etiological agent of a new ulcerative-type
disease termed ‘yaaf’ by the authors.41 Thus, R. felis is currently
extremely common in some African countries (appearing as an
eruptive febrile illness), with evidence in infecting mosquitoes
(genera Anopheles and Aedes) and gorilla stools, suggesting that
these mammals could be potential reservoirs.42,43
Human infection with this Rickettsia species has been described
worldwide. The prevalence of infection in the main suspected
vector (the cat ﬂea, C. felis) is very high and it has been found
all around the world.44 R. felis grows in vitro only at low
temperatures.45
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Figure 5. Algorithm for exanthematic rickettsioses with the probability of an inoculation eschar.
A´.A. Faccini-Martı´nez et al. / International Journal of Infectious Diseases 28 (2014) 126–139 1293.1.2. Rickettsia massiliae infection
To date, only four conﬁrmed human cases of infection with this
species have been published; in all cases an inoculation eschar was
observed. Two of them had a maculopapular rash (Italy and
France),46,47 one was purpuric (Argentina),48 and the remaining
case had no evidence of a rash (Italy); it is likely that warmer
weather has an impact on the epidemiology of this rickettsio-
sis.47,49 R. massiliae usually infects ticks of the Rhipicephalus
sanguineus complex, predominantly in Europe50 and in the USA,51
and it has been identiﬁed recently in the hard tick Dermacentor
marginatus in southern Hungary.52 R. massiliae has been involved
in double infections with R. conorii in R. sanguineus ticks (southern
France).53
3.1.3. Rickettsia parkeri infection
The presence of this Rickettsia, as with R. rickettsii, is
geographically limited to the Western Hemisphere.15 The clinical
manifestations are characterized by a maculopapular rash, in some
cases vesiculopapular, with palmoplantar involvement and, in
more than 90% of cases, associated with single or multiple
inoculation eschars and the possibility of regional lymphadenopa-
thy. Hence, this is one of the few rickettsioses to produce an eschar
in America.54–56 The recognized vectors are Amblyomma macula-
tum and Amblyomma triste.15 However, Amblyomma ovale has
recently been proposed as an alternative vector of a variation of R.
parkeri known as Rickettsia sp. Atlantic rainforest strain, given the
ﬁndings in Colombia57 and Brazil,58 and this is now recognized as a
human pathogen.58 R. parkeri has also been detected in
Amblyomma tigrinum ticks in Cochabamba (Bolivia)59 and in Ixodes
scapularis from Louisiana (USA).60
3.1.4. Rickettsia conorii infection
Since its ﬁrst description as a human pathogen in 1910 until the
end of the last century, this was recognized as the only causative
agent of tick-borne rickettsioses in Europe.50 In 2005, R. conorii was
proposed as a complex with four subspecies based on epidemio-
logical and clinical differences.61 The following subspecies were
recognized: R. conorii subsp. conorii, R. conorii subsp. israelensis, R.
conorii subsp. caspia, and R. conorii subsp. indica, all geographically
restricted to the Eastern Hemisphere. R. conorii subsp. conorii iswidely distributed and is the main cause of exanthematic
rickettsioses associated with inoculation eschar in Mediterranean
countries (European and African) and in the Black Sea.38 Clinically,
patients present with a maculopapular or purpuric rash with
involvement of the palms and soles (Figure 6) and the presence of a
single or multiple inoculation eschars (mainly in children).50 For
the other subspecies, the ﬁnding of an inoculation eschar is less
frequent and their geographical distribution is more restricted.
Patients infected with R. conorii subsp. conorii usually have a single
eschar and a generalized maculopapular rash (97%), and the
mortality rate is close to 2.5%. For R. conorii subsp. caspia, the
symptoms include eschar (23%), a macular rash (94%), and
conjunctivitis; no fatal cases have been reported. R. conorii subsp.
indica frequently presents a purpuric rash, however an eschar is
rarely found and no fatal forms have been reported. Finally, R.
conorii subsp. israelensis rickettsiosis has a lesser presence of
eschar than R. conorii subsp. conorii and results in a mild to severe
illness.38,62 Although the main vector is the brown dog tick R.
sanguineus, other species belonging to the same complex could also
act as vectors.50
3.1.5. Rickettsia sibirica subsp. sibirica infection
This is characterized by a benign evolution with a low
probability of complications.16 Clinically, it presents a maculo-
papular or petechial rash associated with an inoculation eschar
(more than 95% of cases) and regional lymphadenopathy.63 The
geographical distribution is limited to the Asiatic Russia (Siberia)
region and the countries located in the south of Russia (Kazakh-
stan, China, and Mongolia), where the main vectors are ticks of the
genus Dermacentor, especially Dermacentor nuttalli.38,64 In contrast
to the rickettsioses caused by Rickettsia heilongjiangensis, in Siberia,
cases of infection by R. sibirica subsp. sibirica tend to be more
frequent in the months of April and May.64
3.1.6. Rickettsia heilongjiangensis infection
Although this species was originally isolated from Dermacentor
silvarum ticks in 1982 in Heilongjiang Province (China), it was not
recognized as a human pathogen until the late 1990s/early
2000.16,65 Cases often occur in patients 50 years old and during
Table 3
Rickettsioses with a probability of inoculation eschar and a maculopapular/purpuric rash
Rickettsia species Geographical distribution Known vector or possible vectors References
R. felis Worldwide Ctenocephalides felis 44
R. massiliae Conﬁrmed cases in Italy, France, and
Argentina
Species belonging to the Rhipicephalus sanguineus complex 46–51
R. parkeri America
USA, Peru Amblyomma maculatum, Ixodes scapularis (USA) (?) 15,60
Brazil Amblyomma triste, Amblyomma ovale (Rickettsia sp. genotype
Atlantic rainforest)
58
Colombia A. ovale (Rickettsia sp. genotype Atlantic rainforest) (?) 57
Uruguay, Argentina A. triste 15
Bolivia Amblyomma tigrinum 59
R. conorii subsp. conorii Europe R. sanguineus
Mediterranean countries (Portugal,
Spain, France, Italy, Malta, Slovenia,
Croatia, Albania, Greece, Cyprus)
38,50
Countries around the Black Sea
(Ukraine, Bulgaria, Turkey, Georgia)
Africa 38
Algeria, Morocco, Tunisia, Kenya,
Somalia, Chad, Zimbabwe, South Africa
R. conorii subsp. israelensis Europe 50
Portugal, Italy
Africa 94
Tunisia
Asia 38
Israel
R. conorii subsp. indica Asia
India
R. conorii subsp. caspia Europe Rhipicephalus pumilio, R. sanguineus 38,53
Astrakhan, Kosovo, France
Africa
Chad
R. sibirica subsp. sibirica Asia
Siberia Dermacentor nuttalli, Dermacentor marginatus, Dermacentor
silvarum, Dermacentor pictus, Haemaphysalis concinna
38
Kazakhstan D. marginatus 16
China, Mongolia D. nuttalli, Dermacentor sinicus, Dermacentor auratus, D. silvarum,
H. concinna
63
R. heilongjiangensis Asia
China and Eastern Siberia Haemaphysalis japonica douglasi, H. concinna, D. silvarum 38,67
Japan H. concinna 66
R. japonica Asia
Japan Haemaphysalis ﬂava, Haemaphysalis longicornis, Dermacentor
taiwanensis, Ixodes ovatus
16,38
Thailand Haemaphysalis hystricis (R. japonica-like) 70
Korea H. longicornis 95
R. honei Oceania 38,74,96
Flinders Islands and Eastern
Australia (R. honei strain marmionii)
Bothriocroton hydrosauri, Ixodes tasmani, Haemaphysalis
novaeguineae
Asia
Thailand Ixodes granulatus 73
Nepal Rhipicephalus haemaphysaloides (?), I. granulatus (?) 72
R. aeschlimannii Africa
Morocco Hyalomma marginatum marginatum 94
Algeria Hyalomma marginatum marginatum, Hyalomma aegyptium,
Hyalomma dromedarii (?), Hyalomma marginatum ruﬁpes (?)
94,97
South Africa Rhipicephalus appendiculatus 98
Tunisia Hyalomma dromedarii (?) 77
Europe
Greece Rhipicephalus turanicus (?) 78
O. tsutsugamushi Asia 84
Kazakhstan, Uzbekistan, Afghanistan,
Pakistan, India, Nepal, Bangladesh,
Myanmar, Vietnam, Cambodia,
Sri Lanka, Singapore, Brunei, Taiwan
Leptotrombidium deliense
New Guinea, Philippines L. deliense, Leptotrombidium ﬂetcheri
China L. deliense, Leptotrombidium scutellare, Leptotrombidium
gaohuensis
Malaysia L. deliense, L. scutellare, Leptotrombidium arenicola, L. ﬂetcheri
Indonesia L. deliense, L. arenicola, L. ﬂetcheri
Thailand L. deliense, Leptotrombidium chiangraiensis, L. scutellare,
Leptotrombidium imphalum
Japan Leptotrombidium akamushi, L. scutellare, Leptotrombidium
pallidum
Korea L. pallidum, L. scutellare, Neotrombicula japonica (?),
Eushoengastia koreaensis (?)
84,88
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Table 3 (Continued )
Rickettsia species Geographical distribution Known vector or possible vectors References
Southeastern Russia L. pallidum, Leptotrombidium pavlovskyi 84
Arab Emirates (Dubai) Not determined 92
Oceania 84
Northern Australia L. deliense
America 93
Chile Not determined
Table 4
Rickettsioses with a probability of inoculation eschar and a vesicular rash
Rickettsia species Geographical distribution Known vector or possible vectors References
R. africae Africa
East, West and Central region Amblyomma variegatum 16
South Amblyomma hebraeum, Rhipicephalus
(Boophilus) decoloratus (?)
16,104
America 15
Caribbean Islands A. variegatum
R. akari Worldwide Liponyssoides sanguineus 113,115–121,124
Conﬁrmed cases in the USA, Mexico, Ukraine, Croatia,
Holland, Turkey, South Africa and Korea
R. australis Oceania 16
Eastern Australia, Queensland (between the
months of June and November)
Ixodes holocyclus, Ixodes tasmani, Ixodes cornuatus
Table 5
Rickettsioses with a probability of inoculation eschar and regional lymphadenopathy as a main sign
Rickettsia species Geographical distribution Known vector or possible vectors References
R. slovaca Europe Dermacentor marginatus, Dermacentor reticulatus 50,139
Conﬁrmed cases in Portugal, Spain, France,
Italy, Hungary, Bulgaria, Slovakia, Germany
Candidatus R. rioja Europe 130,131
Conﬁrmed cases in Spain D. marginatus
R. raoultii Europe 105,132,143–147
Conﬁrmed case in Slovakia and suspected
cases in Spain, France, Poland
D. marginatus, D. reticulatus, Dermacentor nuttalli (Mongolia),
Dermacentor silvarum (China)
Rickettsia sp. strain
364D (R. philipii)
America 140–142
USA (California) Dermacentor occidentalis
Table 6
Rickettsioses with a probability of inoculation eschar and lymphangitis
Rickettsia species Geographical distribution Known vector or possible vectors References
R. sibirica subsp. mongolitimonae Europe
France and Portugal Rhipicephalus pusillus 154,161
Greece Hyalomma anatolicum excavatum 153
Spain R. pusillus, Hyalomma marginatum (?) 163,164
Africa
Egypt and Algeria Hyalomma sp. 94
South Africa Hyalomma truncatum 152
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tions, the rash is maculopapular and has a mild appearance, and
this is accompanied by other signs including an inoculation eschar,
lymphadenopathy, and, in a small proportion, lymphangitis and
conjunctival injection.65
In 2010, the ﬁrst case of R. heilongjiangensis infection conﬁrmed
by molecular tools was reported in Japan in a 35-year-old man
with rash, fever, and two lesions compatible with inoculation
eschars.66 Although Haemaphysalis japonica douglasi and D.
silvarum are endemic in Eastern Siberia and China, epidemiological
studies have determined Haemaphysalis concinna to be a possible
vector.38,673.1.7. Rickettsia japonica infection
This rickettsiosis was initially mistaken for scrub typhus or O.
tsutsugamushi infection.16 Both infections are characterized by an
acute febrile illness associated with a maculopapular rash,
inoculation eschar, and the possibility of a severe clinical picture
related with pulmonary and neurological complications and
multiorgan failure; both also share a similar geographical
distribution where their vectors (ticks and mites, respectively)
are prevalent.68 However, in the infection caused by R. japonica, the
presence of an inoculation eschar is more common (>90%) than in
scrub typhus. On the other hand, eschar is not associated with
lymphadenopathy is usually observed, and the rash may progress
Figure 6. Purpuric rash affecting the soles of the feet in a patient with Rickettsia
conorii rickettsiosis.
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cases occur in Japan from April to October. The tick vectors
recognized are Haemaphysalis ﬂava, Haemaphysalis longicornis,
Dermacentor taiwanensis, and Ixodes ovatus.16,38 Similarly, this
rickettsiosis has also been described in South Korea and
Thailand.69,70
3.1.8. Rickettsia honei infection
This species was ﬁrst isolated in clinical samples from patients
in the Flinders Islands and is now recognized as the most frequent
species causing tick-borne rickettsioses in Australia after R.
australis.71 Clinical manifestations caused by R. honei include a
maculopapular or purpuric rash without the presence of vesicles
and palmoplantar involvement. An inoculation eschar is seen in
half of the cases. Other signs such as lymphadenopathy and cough
may occur.16 This rickettsiosis is more common during the months
of December and January.16 The recognized vectors in Australia are
Bothriocroton hydrosauri, Haemaphysalis novaeguineae, and Ixodes
tasmani.72
Cases of human infection with this species have also been
reported in Thailand, where the vector is Ixodes granulatus.73 In
Nepal, the same tick species has been suggested as a possible
vector, together with Rhipicephalus haemaphysaloides, as seen in a
case published in 2011.72
In Eastern Australia, during 2003, a genetically related species
of R. honei (marmionii strain) was isolated in patients with fever
and headache. Only a small proportion had rash onset and an
inoculation eschar.74 These cases occurred between February and
June, in contrast to R. honei and R. australis infections.
3.1.9. Rickettsia aeschlimannii infection
This Rickettsia species was ﬁrst isolated in 1997 from Hyalomma
marginatum ticks in Morocco;75 5 years later, the ﬁrst human case
was published involving a patient in the same country.76 Up until
2010, six more cases were attributed to this rickettsiosis (South
Africa, Tunisia, Algeria, and Greece) by molecular and serological
methods.77,78 Most cases started as an acute febrile illness
associated with a maculopapular rash. Only two patients
presented an inoculation eschar. It is remarkable that in the
Algerian cases, one patient had more than one eschar and the other
an associated purpuric rash component.79
R. aeschlimannii has been isolated in different species of
anthropophilic ticks of the genera Hyalomma and Rhipicephalus
from many countries of Africa and Europe. It is considered that
infection with this Rickettsia species may have been under-
diagnosed.77,80 However, a study from the north of Spaindemonstrated the absence of infection or disease by R. aeschli-
mannii in people bitten (even for more than 1 week) by H.
marginatum ticks infected with this Rickettsia.81
3.1.10. Orientia tsutsugamushi infection
Previously included in the genus Rickettsia, this species was
reclassiﬁed in 1995 based on ﬁndings from its cell wall and on
phylogenetic analyses as a single species belonging to the genus
Orientia with different related strains.82–84 Today, rickettsiosis by
O. tsutsugamushi is an important cause of acute febrile illness and is
endemic in the Asian Paciﬁc region, extending from Afghanistan to
China, Korea, the South Paciﬁc Islands, and Northern Australia.84
The eco-epidemiology of this disease is determined by humid
tropical regions where mites of the genus Leptotrombidium, known
as trombiculids or chiggers, are reservoirs of O. tsutsugamushi and
their larval stages act as human vectors.85 Wild rodents are the
main hosts of these mites.86 Endemic regions are characterized by
rice ﬁelds, scrubland, and the presence of primary deforesta-
tion.85,86 In Japan, unlike infection caused by R. japonica, infection
by O. tsutsugamushi is usually more frequent in November.87 Other
genera of the Trombiculidae family, such as Neotrombicula (N.
japonica) and Eushoengastia (E. koreaensis), have also been
implicated as possible vectors.88
The clinical manifestations may vary from mild to severe. Heart
failure, acute renal failure, and central nervous system and
respiratory system compromise, with interstitial pneumonia and
acute respiratory distress syndrome (ARDS) are the most frequent
causes of complications and death.89–91 The incubation period is
usually higher than for other rickettsioses (up to 18–21 days).68,89
The fever usually appears abruptly, associated with headache,
myalgia, and malaise. A week after the onset of these symptoms, a
maculopapular rash with centrifugal distribution may appear
(uncommon) and an inoculation eschar, which can be single or
multiple (presence varies between 7% and 80% of cases), commonly
associated with regional lymphadenopathy. Manifestations such
as non-suppurative conjunctival injection and hearing loss are
highly suggestive of this rickettsiosis.89,91
Human cases of infection by bacteria of the genus Orientia
involving patients with a rash and inoculation eschar in Dubai
(2010) and Chile (2011) have been published.92,93 These geo-
graphical areas are unusual for the occurrence of this disease,
suggesting the presence of ‘new species’ of the genus Orientia.
3.2. Associated with a vesicular rash
3.2.1. Rickettsia africae infection
This rickettsiosis, initially confused with R. conorii infection,
was described in the 1990s by Kelly et al., who determined that it
was produced by a new species belonging to the spotted fever
group (SFG).99,100 This disease begins with an abrupt onset fever,
headache, myalgia (predominantly in the cervical region), and
typically single or multiple inoculation eschars (predominantly in
the extremities), associated with a vesicular rash and lymphade-
nopathy in half of the cases (Figure 7).16 Its epidemiology is
associated with the presence of R. africae in Amblyomma
variegatum (Eastern, Western, and Central Africa and the Caribbean
Islands) and Amblyomma hebraeum (Southern Africa) as its
recognized vectors.15 However, R. africae has also been detected
in other tick species, such as Amblyomma lepidum and Hyalomma
dromedarii in northwest Africa,93,101,102 Amblyomma loculosum in
New Caledonia,103 Rhipicephalus decoloratus in the Republic of
Botswana,104 and Hyalomma aegyptium in Turkey.105 It is currently
recognized as the most common rickettsiosis in European and
American travelers returning from endemic areas of Africa and the
Caribbean Islands.16,106 Figure 8 shows an algorithm for the
approach to patients with rickettsioses and a vesicular rash.
Figure 7. Vesicular rash and eschar on a patient with Rickettsia africae rickettsiosis.
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R. akari together with O. tsutsugamushi are the rickettsial agents
transmitted by mites.107 The ﬁrst clinical manifestation of this
rickettsiosis is a primary papulovesicular lesion at the location of
inoculation at 24–48 h after the bite. This primary lesion becomes
an eschar, frequently associated with regional lymphadenopa-
thy.108 Constitutional symptoms, such as fever, headache, chills,
and myalgia usually occur after a week.109 Characteristically, a
generalized papulovesicular rash appears between 2 and 3 days
after the onset of these symptoms. It is usually distributed on the
face, trunk, and extremities, without compromise of the palms or
soles, and it can be associated with vesicular enanthema on the
palate, tongue, mouth, tonsils, or pharynx.108 The classic triad of
this disease is described as fever, papulovesicular rash, and
inoculation eschar.110 The evolution of this disease is usually
benign in the absence of antibiotic treatment, without associated
mortality.111 In 2008, two cases of acute hepatitis were described
in patients infected with R. akari.112
Liponyssoides sanguineus (Allodermanyssus sanguineus) is the
only vector and reservoir, and the domestic mouse (Mus musculus)
is the primary host of L. sanguineus,113 although this mite has been
found infesting wild and synanthropic rodents.114 The presence of
R. akari has been described in some American countries,115–117
Europe,118,119 Asia,120 and Africa.121 Thus, this disease could have a
worldwide distribution, taking into account the cosmopolitan
behavior of M. musculus and the vector mite.114 It is very likely that
this rickettsiosis is under-diagnosed or confused with other
exanthematic diseases.Syndrome
Type of  rash 
Epidem iolo gical ba ckground  
Rickesia spp.
Rickesioses 
Africa o r Caribbean I sland s 
Ticks : Amblyom ma  genu s
R. africa e 
Figure 8. Algorithm for rickettsioses with the probabi3.2.3. Rickettsia australis infection
Unlike infection by R. honei, with which it shares similar clinical
features, in the rickettsioses caused by R. australis the presence of
an inoculation eschar is more frequent (over 60% of cases),
associated with lymphadenopathy. Characteristically the rash is
mainly vesicular or maculopapular.16 It can present as a moderate
to severe disease, with complications such as renal failure,
fulminant purpura, myopericarditis, pneumonia, splenic infarct,
and vasculitis associated with mortality.38,122
Its distribution is restricted to the Australian territory,
speciﬁcally to the Eastern region, where most cases usually occur
from June to November. Ixodes holocyclus is the main vector;69,123
however R. australis has also been isolated from I. tasmani
(Southern and Western Australia) and from Ixodes cornuatus
(South Australia).16
3.3. Associated with regional lymphadenopathy
Two dominant signs characterize this syndrome: an inoculation
eschar and regional lymphadenopathy. In contrast, the occurrence
of fever and rash is rare. Within this clinical spectrum, the main
syndrome is termed DEBONEL/TIBOLA (Dermacentor-borne ne-
crosis erythema lymphadenopathy/tick-borne lymphadenopathy),
also called SENLAT (scalp eschar and neck lymphadenopathy after
tick bite) by other authors when the tick bite affects only the scalp.
DEBONEL/TIBOLA and SENLAT are produced by different species of
Rickettsia. In the case of SENLAT, other bacteria such as Bartonella
henselae have also been involved.125 The main etiological agent is
Rickettsia slovaca.126,127 This Rickettsia was ﬁrst identiﬁed in D.
marginatus and Dermacentor reticulatus (recognized vectors) in
different European countries (Slovakia, Switzerland, France,
Portugal, Spain, Germany, etc.) and was subsequently isolated
(1997) and implicated as a human pathogen (early 2000) in
France.128,129
Meanwhile, ‘Candidatus Rickettsia rioja’ and Rickettsia raoultii
have also been implicated as secondary etiological agents in Spain.
The former was detected by molecular techniques in clinical
samples (blood and serum of patients) and in D. marginatus ticks
removed from patients with a diagnosis of DEBONEL/TIBOLA in
Spain (half of the cases),130,131 and R. raoultii was detected in ticks
of the genus Dermacentor (mainly D. marginatus) removed from
patients who developed the disease in different regions of
Europe.105,132–134
DEBONEL/TIBOLA is characterized by a benign evolution and a
short incubation period (average 5 days), with a later onset of a
honey-like exudation in the region of the tick bite (>95% in the
scalp), which evolves, within a few days, into an inoculation escharVesicular rash 
wit h probabilit y of  inocula on eschar 
Worldwide 
Mouse  mite
R. akari
Austra lia 
Ticks: Ixod es genu s
R. au strali s
lity of an inoculation eschar and a vesicular rash.
Figure 9. Big eschar and surrounding erythema in a patient with DEBONEL/TIBOLA
(Rickettsia slovaca, Candidatus Rickettsia rioja, and Rickettsia raoultii).
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in other rickettsioses (up to 2 cm) and is associated with painful
regional lymphadenopathy.135When the tick bite is out of the scalp,
the erythema resembles the ‘erythema migrans’ of Lyme disease.
Other symptoms, such as rash, facial edema, and fever, occur in less
than 20% of cases.135 Notably, a third of patients develop persistent
alopecia where the eschar was present.135 DEBONEL/TIBOLA/
SENLAT is currently the second most prevalent tick-borne
rickettsiosis in Europe after that caused by R. conorii,50 with human
cases reported in France, Spain, Hungary, Slovakia, Bulgaria, Italy,
Germany, and Portugal,50,136–139 where it tends to affect mainly
women and children.132,135 A case of this syndrome caused by
R. massiliae reported in Italy has recently been published.49
Figure 10 shows an algorithm for diagnosing this syndrome.
There is another Rickettsia spp. related with this syndrome in
the USA –Rickettsia sp. genotype 364D (Rickettsia philipii). Rickettsia
sp. genotype 364D (R. philipii) was ﬁrst isolated in 1966 in
Dermacentor occidentalis ticks from Ventura County, California
(USA).140 For a long time it was considered non-pathogenic.
However, a case of infection in an 80-year-old man in the state of
California in 2008 and then three pediatric cases in 2011, also in
California, were conﬁrmed.141,142 All cases had a benign course.
Single inoculation eschars associated with regional lymphadenop-
athy are the main clinical signs. A rash is uncommon and is usually
accompanied by mild fever, headache, myalgia, arthralgia, and
malaise.141,142 Currently, this new Rickettsia sp. should be
considered in the differential diagnosis of the rickettsioses that
present an eschar in the USA, as are those caused by R. parkeri and
R. akari.55Syndrome
Oth er clini cal   
characteriscs
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Figure 10. Algorithm for rickettsioses with predom3.4. Associated with lymphangitis
Lymphangitis is a clinical sign that may be present in several
rickettsioses. Half of the cases of R. sibirica subsp. mongolitimonae
infection present this sign (rope-like lymphangitis between the
inoculation eschar and lymphadenitis) (Figure 11). This ﬁnding has
led to the infection being termed lymphangitis-associated rick-
ettsiosis (LAR). Lymphangitis is also present in those infections
caused by R. heilongjiangensis and R. africae,16 although in a lesser
proportion than in R. sibirica mongolitimonae infection.50 This
species was ﬁrst isolated in 1991 in Hyalomma asiaticum ticks from
inner Mongolia (China).148 Five years later, its role as human
pathogen was conﬁrmed in France and there are 26 more cases
reported in the literature.149–162 A single eschar is present in 80% of
cases (only two cases with two eschars),151 associated with
regional lymphadenopathy and a maculopapular rash affecting the
palms and soles (70% of cases).160,162 Although the course of
disease is benign in most cases, severe cases with septic shock160
and acute renal failure have been reported.153 Ocular involvement
(retinal vasculitis) has also been described.156
Regarding its epidemiology, most cases have occurred in
France, Spain, and Portugal.50 It has also been reported from
Algeria,151 South Africa,152 Greece,153 and Egypt.158 The tick
species involved as vectors are related to ticks of the genus
Hyalomma, such as H. truncatum152 and H. anatolicum excavatum153
and Rhipicephalus pusillus in France,161 Spain,163,164 and
Portugal.154
4. Other rickettsioses without assigned classiﬁcation
Because of the few cases described or the not reliable clinical
features, some rickettsioses have not been assigned to any
proposed syndrome in this article.
4.1. Rickettsia helvetica infection
This is also known as the non-eruptive rickettsiosis.1 It has been
reported only in Switzerland, Sweden, France, and Italy, where
most patients have presented with isolated fever (no rash or
inoculation eschar).50 However, some cases in Sweden have
presented rash,165 perimyocarditis,166 and meningitis.167 The
main vector is Ixodes ricinus.50
4.2. Rickettsia monacensis infection
Two cases have been reported from Spain (2007) and one from
Italy (2012).168,169 The Spanish cases presented with a febrilel lymphad enopath y 
ocula on  eschar (>95% in scalp)  
California  (USA) 
Ticks: D. occidentalis
Rickesia sp genotyp e 364D  (R. ph ilipii ) 
inant signs of eschar and lymphadenopathy.
Figure 11. Lymphangitis and eschar on a patient with lymphangitis-associated
rickettsiosis (LAR) (Rickettsia sibirica mongolitimonae infection). Courtesy of Dr Rita
de Sousa.
Figure 12. Algorithm for microbiolo
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presented with fever associated with an inoculation eschar and
without rash. I. ricinus is the suspected vector of this rickettsial
species.50
4.3. Candidatus Rickettsia kellyi infection
The only case reported was conﬁrmed by molecular, histopath-
ological, and serological methods. It involved a child from India
who had a febrile illness associated with a maculopapular rash that
affected the face, back, and limbs, including the palms and soles.170
The vector is unknown.
4.4. Rickettsia tamurae infection
Only one case of R. tamurae infection has been reported.171 This
involved a Japanese patient who presented with an inﬂammatory
reaction in the popliteal region of his leg, secondary to the bite of a
tick identiﬁed as Amblyomma testudinarium. It was possible to
obtain molecular evidence of R. tamurae in the patient’s blood and
skin lesions, and in the tick.
5. Microbiological diagnosis
There are several different approaches to the diagnosis of
human rickettsioses. As for other bacterial infectious diseases, the
gold standard is culture. This approach is difﬁcult because it
requires appropriate laboratories and trained people, so it is only
performed in reference centers with P3 level biosafety laboratories.
However, the shell vial technique has facilitated the inclusion
of culture in clinical microbiology laboratories. The sample must
be processed quickly (in a few hours) or must be stored
correctly.172,173
In recent years, molecular tools have been incorporated into the
routine methods of a great number of laboratories. Molecular tools
such as PCR and quantitative PCR (qPCR) are increasingly used. The
most common ones are those that use the ampliﬁcation of different
preserved genes of the genus Rickettsia (gltA, ompA, ompB, sca4,
htrA, and 16S rDNA).174 This procedure allows a speciﬁc, sensitive,gical diagnosis of rickettsioses.
Table 7
Treatment of rickettsioses; based on Botelho-Nevers et al., 201262
Antibiotic Indications Dosage Duration of treatment
Doxycycline (standard
treatment for
rickettsioses)
 Severe rickettsioses (including
pregnant women and children),
ideally intravenous
 Adults or children >45 kg
 Adults or children >45 kg: 100 mg twice a day
 Pregnant women (late trimester): 100 mg twice a day
 Children <45 kg: 2.2 mg/kg twice a day
Continued for 3 days after
symptoms have resolved
Macrolides (josamycin,
clarithromycin, and
azithromycin)
 Option for not severe rickettsioses
in children and pregnant women
 Josamycin: children 50 mg/kg twice a day,
pregnant women 1 g/8 h
 Clarithromycin for children: 15 mg/kg/day divided doses
 Azithromycin for children: 10 mg/kg/day in 1 dose
Josamycin 5 days,
clarithromycin 7 days,
and azithromycin
3 days
Chloramphenicol  Alternative option in severe
rickettsioses
 Adults and pregnant women (ﬁrst and second trimesters):
60–75 mg/kg/day in 4 divided doses
 Children: 12.5–25 mg/kg every 6 h
5–10 days
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biopsy, eschar, removed tick, and others) are processed correct-
ly.172,173 The use of a swab in cases where an eschar is present is
very useful for the diagnosis by PCR.56,175
In most clinical microbiology laboratories, the diagnosis is
made by the detection of antibodies measured using serological
assays. Immunoﬂuorescence (IFA) remains the reference method
for this approach. However, it is not speciﬁc (cross-reactions
among species) and is not sensitive in the ﬁrst days of infection. To
obtain the diagnosis it is necessary to study two samples (acute
and convalescent sera), waiting at least 2 weeks between them. IgG
and IgM can be studied, although the latter can frequently produce
false-positive results. To obtain an accurate diagnosis it is
necessary to observe seroconversion (4-fold increase in titer).
In some reference laboratories, cross-absortion and Western blot
are performed to increase the speciﬁcity.172,173 Figure 12 shows an
algorithm useful for the diagnosis.
6. Treatment of rickettsioses
Since rickettsioses are a threat to human life, empirical
treatment must be started when they are suspected. Physicians
should never wait for laboratory results. Doxycycline is the drug of
choice for all of the known rickettsioses, even in children and
pregnant women when the woman has a severe infection.176 For
some rickettsioses such as Mediterranean spotted fever, a short
course of doxycycline has been demonstrated to be effective and
safe (doxycycline 200 mg twice daily for only 1 day).177 As an
alternative to doxycycline (allergic patients, pregnant women),
macrolides such as azithromycin or josamycin can be used. The use
of quinolones is not recommended because it has been associated
with an increased mortality.178
A review on the prevention of tick-borne diseases has recently
been published, which provides useful information for the
prevention and prophylaxis of tick-borne rickettsioses.179
Table 7 describes the duration, dosage, and other considerations
of the most commonly used treatments for rickettsioses in adults,
children, and pregnant women.62
7. Conclusions
In the last two decades, with the development of new
diagnostic methods, mainly based on molecular biology, the
characterization and involvement of new species of Rickettsia as
etiological agents of human diseases worldwide have increased
considerably. Clinical manifestations combined with a thorough
history (travel, epidemiological environment, and place of resi-
dence) and knowledge of the distribution of rickettsial agents and
their vectors may help clinicians to correctly diagnose a
rickettsiosis. This is especially relevant when microbiologicalidentiﬁcation of the microorganism is impossible (for example, due
to previous prescription of antimicrobials, or if a microbiology
laboratory or other available techniques are missing). The aim of
this review was to provide physicians with a diagnostic approach,
taking into account the common signs and symptoms of these
diseases. Nevertheless, to achieve a deﬁnitive diagnosis, microbi-
ological assays are needed.
Of note, the fact that one of these clinical syndromes is not
compatible with the expected geographical distribution may
suggest the emergence of a previously unknown species, new
species, or even new clinical manifestations.
Finally, despite being outside of the objective of this paper, we
would like to emphasize that antibiotic treatment with doxycy-
cline (including for children) must be started whenever a possible
rickettsiosis is suspected, taking into consideration pregnant
women and allergic patients.
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